IS INSULIN-RESISTANCE LINKED TO HYPERTENSION

Citation
Mw. Brands et al., IS INSULIN-RESISTANCE LINKED TO HYPERTENSION, Clinical and experimental pharmacology and physiology, 25(1), 1998, pp. 70-76
Citations number
66
Categorie Soggetti
Pharmacology & Pharmacy",Physiology
ISSN journal
03051870
Volume
25
Issue
1
Year of publication
1998
Pages
70 - 76
Database
ISI
SICI code
0305-1870(1998)25:1<70:IILTH>2.0.ZU;2-8
Abstract
1. The volume of work reporting insulin resistance in multiple forms o f chronic hypertension has generated tremendous interest in whether th is abnormality is an important factor in causing hypertension, Insulin resistance, however, is an imprecise term used interchangeably to des cribe widely disparate types of impairment in insulin action throughou t the body and the type of insulin resistance has major ramifications regarding its potential for inducing long-term increases in blood pres sure (BP). 2. Hepatic insulin resistance (impaired insulin-mediated su ppression of hepatic glucose output) is the primary cause of fasting h yperinsulinaemia and is a cardinal feature of obesity hypertension. Ev idence from chronic insulin infusion studies in rats suggests hyperins ulinaemia can increase BP under some conditions; however, conflicting evidence in humans and dogs leaves in question whether hyperinsulinaem ia is a factor in hypertension induced by obesity. 3. Peripheral insul in resistance (impaired insulin-mediated glucose uptake, primarily of an acute glucose load in skeletal muscle) also present in obesity hype rtension, but now reported in lean essential hypertension as well, is linked most notably to impaired insulin-mediated skeletal muscle vasod ilation. This derangement has also been proposed as a mechanism throug h which insulin resistance can cause hypertension. 4. The present revi ew will discuss the lack of experimental or theoretical support for th at hypothesis and will suggest that a direct link between insulin resi stance and BP control map not be the best way to envision a role for i nsulin resistance in cardiovascular morbidity and mortality.